In collaboration with the Swiss government and other Swiss organisations, the program will address the newest developments in regard to harm reduction policy and practice and offers an ideal platform for discussion and dialogue.
Particular focus will be given to drug policy reform, the involvement and impact of drug user organisations and the impact of the financial crisis on harm reduction. A specific session will discuss and stimulate the collaboration between drug consumption rooms in Europe.
Members of EuroHRN are asked to contribute to the conference and to submit abstracts for one of the priority topics.
More details will be provided soon on this website and through the EuroHRN newsletters.
See also the specific conference website at www.harmreduction.ch for more information and registration.